167 related articles for article (PubMed ID: 27964881)
21. Enzymatic and Biological Characterization of Novel Sirtuin Modulators against Cancer.
Carafa V; Poziello A; Della Torre L; Giovannelli P; Di Donato M; Safadeh E; Yu Z; Baldi A; Castoria G; Tomaselli D; Mai A; Rotili D; Nebbioso A; Altucci L
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31726691
[TBL] [Abstract][Full Text] [Related]
22. A Glycoconjugated SIRT2 Inhibitor with Aqueous Solubility Allows Structure-Based Design of SIRT2 Inhibitors.
Hong JY; Price IR; Bai JJ; Lin H
ACS Chem Biol; 2019 Aug; 14(8):1802-1810. PubMed ID: 31373792
[TBL] [Abstract][Full Text] [Related]
23. Development of activity-based probes for the protein deacylase Sirt1.
Goetz CJ; Sprague DJ; Smith BC
Bioorg Chem; 2020 Nov; 104():104232. PubMed ID: 32911193
[TBL] [Abstract][Full Text] [Related]
24. Discovery of thieno[3,2-d]pyrimidine-6-carboxamides as potent inhibitors of SIRT1, SIRT2, and SIRT3.
Disch JS; Evindar G; Chiu CH; Blum CA; Dai H; Jin L; Schuman E; Lind KE; Belyanskaya SL; Deng J; Coppo F; Aquilani L; Graybill TL; Cuozzo JW; Lavu S; Mao C; Vlasuk GP; Perni RB
J Med Chem; 2013 May; 56(9):3666-79. PubMed ID: 23570514
[TBL] [Abstract][Full Text] [Related]
25. Cyclic tripeptide-based potent human SIRT7 inhibitors.
Li S; Wu B; Zheng W
Bioorg Med Chem Lett; 2019 Feb; 29(3):461-465. PubMed ID: 30578034
[TBL] [Abstract][Full Text] [Related]
26. The Fungal Metabolite Eurochevalierine, a Sequiterpene Alkaloid, Displays Anti-Cancer Properties through Selective Sirtuin 1/2 Inhibition.
Schnekenburger M; Mathieu V; Lefranc F; Jang JY; Masi M; Kijjoa A; Evidente A; Kim HJ; Kiss R; Dicato M; Han BW; Diederich M
Molecules; 2018 Feb; 23(2):. PubMed ID: 29401749
[TBL] [Abstract][Full Text] [Related]
27. SIRT1, 2, 3 protect mouse oocytes from postovulatory aging.
Zhang T; Zhou Y; Li L; Wang HH; Ma XS; Qian WP; Shen W; Schatten H; Sun QY
Aging (Albany NY); 2016 Apr; 8(4):685-96. PubMed ID: 26974211
[TBL] [Abstract][Full Text] [Related]
28. Human SIRT3 tripeptidic inhibitors containing N(ε)-thioacetyl-lysine.
Chen B; Wang J; Huang Y; Zheng W
Bioorg Med Chem Lett; 2015 Sep; 25(17):3481-7. PubMed ID: 26220157
[TBL] [Abstract][Full Text] [Related]
29. N(epsilon)-thioacetyl-lysine-containing tri-, tetra-, and pentapeptides as SIRT1 and SIRT2 inhibitors.
Kiviranta PH; Suuronen T; Wallén EA; Leppänen J; Tervonen J; Kyrylenko S; Salminen A; Poso A; Jarho EM
J Med Chem; 2009 Apr; 52(7):2153-6. PubMed ID: 19296597
[TBL] [Abstract][Full Text] [Related]
30. Identification of a Selective SIRT2 Inhibitor and Its Anti-breast Cancer Activity.
Shah AA; Ito A; Nakata A; Yoshida M
Biol Pharm Bull; 2016; 39(10):1739-1742. PubMed ID: 27725455
[TBL] [Abstract][Full Text] [Related]
31. Tetrahydroindoles as Multipurpose Screening Compounds and Novel Sirtuin Inhibitors.
Vojacek S; Schulig L; Wössner N; Geist N; Langel W; Jung M; Schade D; Link A
ChemMedChem; 2019 Apr; 14(8):853-864. PubMed ID: 30811852
[TBL] [Abstract][Full Text] [Related]
32. Two-step synthesis of novel, bioactive derivatives of the ubiquitous cofactor nicotinamide adenine dinucleotide (NAD).
Pesnot T; Kempter J; Schemies J; Pergolizzi G; Uciechowska U; Rumpf T; Sippl W; Jung M; Wagner GK
J Med Chem; 2011 May; 54(10):3492-9. PubMed ID: 21528845
[TBL] [Abstract][Full Text] [Related]
33. Structural Basis of Sirtuin 6 Inhibition by the Hydroxamate Trichostatin A: Implications for Protein Deacylase Drug Development.
You W; Steegborn C
J Med Chem; 2018 Dec; 61(23):10922-10928. PubMed ID: 30395713
[TBL] [Abstract][Full Text] [Related]
34. Substrate specificity of SIRT1-catalyzed lysine Nepsilon-deacetylation reaction probed with the side chain modified Nepsilon-acetyl-lysine analogs.
Jamonnak N; Hirsch BM; Pang Y; Zheng W
Bioorg Chem; 2010 Feb; 38(1):17-25. PubMed ID: 19914676
[TBL] [Abstract][Full Text] [Related]
35. Identification of Bichalcones as Sirtuin Inhibitors by Virtual Screening and In Vitro Testing.
Karaman B; Alhalabi Z; Swyter S; Mihigo SO; Andrae-Marobela K; Jung M; Sippl W; Ntie-Kang F
Molecules; 2018 Feb; 23(2):. PubMed ID: 29443909
[TBL] [Abstract][Full Text] [Related]
36. SirT1 confers hypoxia-induced radioresistance via the modulation of c-Myc stabilization on hepatoma cells.
Xie Y; Zhang J; Xu Y; Shao C
J Radiat Res; 2012; 53(1):44-50. PubMed ID: 22302044
[TBL] [Abstract][Full Text] [Related]
37. Discovery and characterization of small molecule SIRT3-specific inhibitors as revealed by mass spectrometry.
Loharch S; Chhabra S; Kumar A; Swarup S; Parkesh R
Bioorg Chem; 2021 May; 110():104768. PubMed ID: 33676042
[TBL] [Abstract][Full Text] [Related]
38. SIRT1 inhibition by melatonin exerts antitumor activity in human osteosarcoma cells.
Cheng Y; Cai L; Jiang P; Wang J; Gao C; Feng H; Wang C; Pan H; Yang Y
Eur J Pharmacol; 2013 Sep; 715(1-3):219-29. PubMed ID: 23726949
[TBL] [Abstract][Full Text] [Related]
39. Hit evaluation results in 5-benzyl-1,3,4-thiadiazole-2-carboxamide based SIRT2-selective inhibitor with improved affinity and selectivity.
Gozelle M; Kaya SG; Aksel AB; Ozkan E; Bakar-Ates F; Ozkan Y; Eren G
Bioorg Chem; 2022 Jun; 123():105746. PubMed ID: 35358824
[TBL] [Abstract][Full Text] [Related]
40. Finding Potent Sirt Inhibitor in Coffee: Isolation, Confirmation and Synthesis of Javamide-II (N-Caffeoyltryptophan) as Sirt1/2 Inhibitor.
Park JB
PLoS One; 2016; 11(3):e0150392. PubMed ID: 26986569
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
